Pre-exposure prophylaxis for South African adolescents: What evidence?

South African Medical Journal

Volumn 105, Issue 11, 2015, Pages 907-911

  Bekker, L G ^a   Gill, K ^a   Wallace, M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; CONDOM USE; DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MEN WHO HAVE SEX WITH MEN; PRE-EXPOSURE PROPHYLAXIS; PREVALENCE; REVIEW; SEXUAL ABSTINENCE; SEXUAL BEHAVIOR; SOUTH AFRICAN; TRANSGENDER; FEMALE; HIV INFECTIONS; MALE; ORAL DRUG ADMINISTRATION; SOUTH AFRICA;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PRE-EXPOSURE PROPHYLAXIS; SOUTH AFRICA;

EID: 84946771802     PISSN: 02569574     EISSN: 20785135     Source Type: Journal    
DOI: 10.7196/SAMJ.2015.v105i11.10222     Document Type: Review

References (39)

1. Dellar RC, Dlamini S, Abdool Karim Q. Adolescent girls and young women: Key populations for HIV epidemic control. J Int AIDS Soc 2015;18(Suppl 1):19408.[http://dx.doi.org/10.7448/IAS.18.2.19408]
2. World Health Organization. Health for the World’s Adolescents: A Second Chance in the Second Decade. Geneva: WHO, 2014. http://apps.who.int/adolescent/second-decade/files/1612_MNCAH_ HWA_Executive_Summary.pdf (accessed 15 July 2014).
3. Bekker L-G, Johnson L, Wallace M, Hosek S. Building our youth for the future. J Int AIDS Soc 2015;18(Suppl 1):20027. [http://doi.org/10.7448/IAS.18.2.20027]
4. Gulliver A, Griffiths KM, Christensen H. Perceived barriers and facilitators to mental health helpseeking in young people: A systematic review. BMC Psychiatry 2010;10(1):113.[http://dx.doi. org/10.1186/1471-244X-10-113]
5. Delany-Moretlwe S, Cowan F, Busza J, Bolton-Moore C, Kelley K, Fairlie L. Providing comprehensive health services for young key populations: Needs, barriers and gaps. J Int AIDS Soc 2015;18(Suppl 1):19833.[http://dx.doi.org/10.7448/IAS.18.2.19833]
6. DiClemente RJ, Salazar LF, Crosby RA, Rosenthal SL. Prevention and control of sexually transmitted infections among adolescents: The importance of a socio-ecological perspective – a commentary. Public Health 2005;119(9):825-883.[http://dx.doi.org/10.1016/j.puhe.2004.10.015]
7. Pettifor AE, Levandowski BA, Macphail C, et al. A tale of two countries: Rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health 2011;49(3):237-243. [http://dx.doi.org/10.1093/ije/dyn131]
8. Eaton L, Flisher AJ, Aarø LE. Unsafe sexual behaviour in South African youth. Soc Sci Med 2003;56(1):149-165. [http://dx.doi.org/10.1016/S0277-9536(02)00017-5]
9. Jaspan HB, Berwick JR, Myer L, et al. Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. J Adolesc Health 2006;39(5):642–648. [http://dx.doi.org/10.1016/j. jadohealth.2006.05.016]
10. Wood K, Maforah F, Jewkes R. ‘He forced me to love him’: Putting violence on adolescent sexual health agendas. Soc Sci Med 1998;47(2):233-242.[http://dx.doi.org/10.1016/S0277-9536(98)00057-4]
11. Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: A cohort study. Lancet 2010;376(9734):41-48.[http://dx.doi.org/10.1016/S0140-6736(10)60548-X]
12. Pettifor AE, Measham DM, Rees HV, Padian NS. Sexual power and HIV risk, South Africa. Emerg Infect Dis 2004;10(11). [http://dx.doi.org/10.3201/eid1011.040252]
13. Stein Z. HIV prevention: The need for methods women can use. Am J Public Health 1990;80(4):460-462.[http://dx.doi.org/10.2105/AJPH.80.4.460]
14. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363(27):2587-2599. [http://dx.doi.org/10.1056/NEJMoa1011205]
15. World Health Organization.Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.2015. WWW.who.int (accessed 1 October 2015).
16. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367(5):411-422. [http://dx.doi.org/10.1056/NEJMoa1202614]
17. Marrazzo JM, Ramjee G, Richardson B, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med 2015;372:509-518. [http://dx.doi.org/10.1056/NEJMoa1402269]
18. Heffron R, Baeten J. Tenofovir-based oral PrEP prevents HIV infection among women. Curr Opin HIV AIDS (in press).
19. Smith DK, Koenig LJ, Martin M. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Practice Guideline. US Public Health Service CDC, 2014:67.
20. Bauermeister JA, Meanley S, Pingel E, et al. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res 2013;11(7):520-527.[http://dx.doi.org/10.2174/1570162X12666140129100411]
21. Rucinski KB, Mensah MP, Sepkowitz KA, et al. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav 2013;17(6):2180-2184. [http://dx.doi.org/10.1007/s10461-013-0443-y]
22. Kubicek K, Arauz-Cuadra C, Kipke MD. Attitudes and perceptions of biomedical HIV prevention methods: Voices from young men who have sex with men. Arch Sex Behav 2015;44(2):487-497.[http://dx.doi.org/10.1007/s10508-014-0398-8]
23. Pérez-Figueroa RE, Kapadia F, Barton S, et al. Acceptability of PrEP uptake among racially/ethnically diverse young men who have sex with men: The P18 Study. AIDS Educ Prev 2015;27(2):112-125.[http://dx.doi.org/10.1521/aeap.2015.27.2.112]
24. Smith DK, Toledo L, Smith D-F, et al. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev 2012;24(5):408-421.[http://dx.doi.org/10.1521/aeap.2012.24.5.408]
25. Mustanski B, Johnson AK, Garafalo R, et al. Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men. AIDS Behav 2013;17(6):2173-2179. [http://dx.doi.org/10.1007/s10461-012-0359-y]
26. Mack N, Evens E, Tolley EE, et al. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: A qualitative study. J Int AIDS Soc 2014;17(Suppl 2):19157. [http://dx.doi.org/10.7448/IAS.17.3.19157]
27. Eisingerich AB, Wheelock A, Gomez G, et al. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One 2012;7(1):e28238. [http://dx.doi.org/10.1371/journal.pone.0028238]
28. Bekker L-G, Glidden DV, Hosek S, et al. PrEP in young MSM: Needs and challenges. Presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2013, Atlanta, USA. http://retroconference.org(accessed 17 October 2015).
29. Hosek S, Siberry G, Bell M, et al. Project PrEPare (ATN082): The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM). J Acquir Immune Defic Syndr 2013;62(4):447-456.[http://dx.doi.org/10.1097/QAI.0b013e3182801081]
30. Hosek S, Rudy B, Landovitz R, et al. An HIV pre-exposure prophylaxis demonstration project and safety study for young men who have sex with men in the United States (ATN 110). J Int AIDS Soc 2015;18.
31. Grant R, Anderson PL, MacMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infect Dis 2014;14(9):820-829. [http://dx.doi.org/10.1016/S1473-3099(14)70847]
32. Baeten J, Heffron R, Kidoguchi L. Near elimination of HIV transmission in a demonstration project of PrEP and ART. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2015), Seattle, USA, 23-26 February 2015.
33. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2015. Published online September 10, 2015. [http://dx.doi.org/10.1016/S0140-6736(15)00056-2]
34. Bekker LG, Hughes J, Amico R, et al. HPTN 067/ADAPT Cape Town: A comparison of daily and nondaily PrEP dosing in African women. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2015), Seattle, USA, 23-26 February 2015, Poster No. 978LB.
35. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: Where have we been and where are we going? J Acquir Immune Defic Syndr 2013;63(Suppl 2):S122-S129.[http://dx.doi.org/10.1097/QAI.0b013e3182986f69]
36. Pettifor A, Nguyen N, Celum C, et al. Tailored combination prevention packages and PrEP for young key populations. J AIDS Soc 2015;18(Suppl 1):19434. [http://dx.doi.org/10.7448/IAS.18.2.19434]
37. AVAC, Global Advocacy for HIV Prevention, New York City, USA. Combination prevention. http://www.avac.org/infographic/defining-combination-prevention-ongoing-trials-sub-saharan-africa (accessed 10 October 2015).
38. USAID. USAID announces microbicide awards. 6 August 2015. https://www.usaid.gov/what-we-do/global-health/hiv-and-aids/technical-areas/microbicides-providing-hiv-prevention-option/2015-microbicide-awards (accessed 18 October 2015).
39. PEPFAR: The US President’s Emergency Plan for AIDS Relief, the Bill & Melinda Gates Foundation, and the Nike Foundation partner on $210 million initiative to reduce new HIV infections in adolescent girls and young women. 1 December 2014. http://www.pepfar.gov/press/releases/2014/234531.htm (accessed 18 October 2015).